
Industry
Medical - Instruments & Supplies
Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. It offers Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. The company was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.
Loading...
Open
10.44
Mkt cap
365M
Volume
71K
High
10.63
P/E Ratio
-5.38
52-wk high
16.08
Low
10.35
Div yield
N/A
52-wk low
6.76
Portfolio Pulse from Avi Kapoor
January 30, 2024 | 10:10 am
Portfolio Pulse from Avi Kapoor
January 24, 2024 | 6:05 pm
Portfolio Pulse from Benzinga Newsdesk
January 09, 2024 | 9:10 pm
Portfolio Pulse from Benzinga Newsdesk
January 09, 2024 | 9:09 pm
Portfolio Pulse from Benzinga Insights
December 11, 2023 | 6:00 pm
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.